Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA

Sponsor
DePuy Orthopaedics (Industry)
Overall Status
Completed
CT.gov ID
NCT00289094
Collaborator
(none)
99
2
2
102
49.5
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the clinical performance of the rotating platform and fixed bearing implants in patients undergoing primary total knee replacement. Outcome scoring and radiographic assessment will be the methods used to evaluate performance.

Condition or Disease Intervention/Treatment Phase
  • Device: Total Knee Replacement
  • Device: Total knee replacement
N/A

Detailed Description

This study will evaluate the clinical performance of rotating platform and fixed bearing knee implants. This will be done by obtaining a series of primary total knee replacements. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Retaining Knee System or the P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System and assignment is randomized.

Study Design

Study Type:
Interventional
Actual Enrollment :
99 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Multi-center, Prospective, Clinical Evaluation of the PFC Sigma Rotating Platform Cruciate Retaining Versus PFC Sigma Cruciate Retaining Knee Primary Cases
Study Start Date :
Mar 1, 2001
Actual Primary Completion Date :
Sep 1, 2009
Actual Study Completion Date :
Sep 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System

Device: Total Knee Replacement
Rotating Platform (RP) Cruciate Retaining Knee System
Other Names:
  • P.F.C.® Sigma™ RP Cruciate Retaining Knee System
  • Active Comparator: 2

    P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System

    Device: Total knee replacement
    Fixed Cruciate Retaining Knee System
    Other Names:
  • P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System
  • Outcome Measures

    Primary Outcome Measures

    1. Knee Society Scores [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]

      The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and < 60 = poor.

    Secondary Outcome Measures

    1. Complications/Revisions [On-going to end of study.]

    2. Medical Imaging [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]

    3. SF-12 Patient Outcomes [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Osteoarthritis

    • Rheumatoid Arthritis

    • Other inflammatory arthritis

    • Avascular necrosis of bone

    Exclusion Criteria:
    • Prior ipsilateral TKA

    • Metabolic disorders

    • Joint replacement due to autoimmune disorders

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Billings Montana United States 59101
    2 Vancouver Washington United States 98664

    Sponsors and Collaborators

    • DePuy Orthopaedics

    Investigators

    • Study Director: Tammy L O'Dell, EMT, CCRA, CCRC, DePuy Orthopaedics

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    DePuy Orthopaedics
    ClinicalTrials.gov Identifier:
    NCT00289094
    Other Study ID Numbers:
    • SRP-2
    First Posted:
    Feb 9, 2006
    Last Update Posted:
    Aug 14, 2013
    Last Verified:
    Aug 1, 2013

    Study Results

    Participant Flow

    Recruitment Details Two US clinical centers performed 99 primary knee replacements in 86 subjects. Recruitment was based on the inclusion and exclusion criteria as specified in the clinical investigation plan.
    Pre-assignment Detail Immediately before surgery, the implant type was determined according to the randomization schedule. Before treatment assignment, consented subjects could be excluded from the trial based on results of pre-operative clinical evaluations and/or radiographs, as per the exclusion criteria in the CIP.
    Arm/Group Title Rotating Platform Fixed Bearing
    Arm/Group Description P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base.
    Period Title: Overall Study
    STARTED 50 49
    COMPLETED 3 2
    NOT COMPLETED 47 47

    Baseline Characteristics

    Arm/Group Title Rotating Platform Fixed Bearing Total
    Arm/Group Description P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base. Total of all reporting groups
    Overall Participants 50 49 99
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    63.7
    (6.2)
    66.9
    (5.1)
    65.3
    (5.9)
    Sex: Female, Male (Count of Participants)
    Female
    31
    62%
    26
    53.1%
    57
    57.6%
    Male
    19
    38%
    23
    46.9%
    42
    42.4%
    Region of Enrollment (participants) [Number]
    United States
    50
    100%
    49
    100%
    99
    100%

    Outcome Measures

    1. Primary Outcome
    Title Knee Society Scores
    Description The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and < 60 = poor.
    Time Frame Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Rotating Platform Fixed Bearing
    Arm/Group Description P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base.
    Measure Participants 50 49
    Pre-operative
    40.8
    (19.8)
    43.4
    (23.0)
    6 months
    84.3
    (14.7)
    77.8
    (14.9)
    12 months
    86.4
    (13.0)
    86.4
    (10.0)
    24 months
    89.7
    (9.2)
    88.1
    (8.8)
    36 months
    92.3
    (8.2)
    87.1
    (10.4)
    48 months
    94.3
    (5.6)
    86.0
    (14.7)
    60 months
    95.0
    (4.6)
    95.5
    (3.5)
    2. Secondary Outcome
    Title Complications/Revisions
    Description
    Time Frame On-going to end of study.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description
    3. Secondary Outcome
    Title Medical Imaging
    Description
    Time Frame Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description
    4. Secondary Outcome
    Title SF-12 Patient Outcomes
    Description
    Time Frame Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Rotating Platform Fixed Bearing
    Arm/Group Description P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base.
    All Cause Mortality
    Rotating Platform Fixed Bearing
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Rotating Platform Fixed Bearing
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 3/50 (6%) 1/49 (2%)
    Cardiac disorders
    Cardiacvascular arrhythmia 2/50 (4%) 2 0/49 (0%) 0
    General disorders
    Death 1/50 (2%) 1 0/49 (0%) 0
    Musculoskeletal and connective tissue disorders
    Femoral Fracture 0/50 (0%) 0 1/49 (2%) 1
    Other (Not Including Serious) Adverse Events
    Rotating Platform Fixed Bearing
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/50 (0%) 0/49 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.

    Results Point of Contact

    Name/Title Tammy O'Dell, EMT, CCRA
    Organization DePuy Orthopaedics, Inc.
    Phone 574-372-7104
    Email TOdell2@its.jnj.com
    Responsible Party:
    DePuy Orthopaedics
    ClinicalTrials.gov Identifier:
    NCT00289094
    Other Study ID Numbers:
    • SRP-2
    First Posted:
    Feb 9, 2006
    Last Update Posted:
    Aug 14, 2013
    Last Verified:
    Aug 1, 2013